TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medicure ( (TSE:MPH) ) has issued an announcement.
Medicure reported a significant increase in total net revenue for the quarter ended September 30, 2025, reaching $8.2 million compared to $5.2 million in the same period the previous year. Despite a decrease in AGGRASTAT® sales due to generic competition, the company saw growth in its Marley Drug business and new acquisitions like Gateway and West Olympia Pharmacies. However, the quarter ended with a net loss of $1.4 million, attributed to increased R&D investments and pricing pressures, impacting its overall financial performance.
The most recent analyst rating on (TSE:MPH) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Medicure stock, see the TSE:MPH Stock Forecast page.
Spark’s Take on TSE:MPH Stock
According to Spark, TipRanks’ AI Analyst, TSE:MPH is a Neutral.
Medicure’s overall stock score is primarily impacted by its financial performance and valuation. The company’s challenges in profitability and cash flow, combined with a negative P/E ratio, weigh heavily on the score. Technical indicators suggest a cautious outlook, with the stock trading below key moving averages. The absence of earnings call data and notable corporate events means these factors do not influence the score.
To see Spark’s full report on TSE:MPH stock, click here.
More about Medicure
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of healthcare products in the United States market. Its primary products include AGGRASTAT®, ZYPITAMAG®, and offerings through its Marley Drug business, with a market focus on both insured and cash sales through various pharmacy channels.
Average Trading Volume: 4,734
Technical Sentiment Signal: Sell
Current Market Cap: C$13.46M
See more insights into MPH stock on TipRanks’ Stock Analysis page.